MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)
Phase 2
Completed
- Conditions
- Rhinitis Allergic
- Registration Number
- NCT00446186
- Lead Sponsor
- Organon and Co
- Brief Summary
The clinical study evaluates the efficacy and safety of MK0476 in adult patients with allergic rhinitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 945
Inclusion Criteria
- Adult patients with seasonal allergic rhinitis
Exclusion Criteria
- Patients who have nasal diseases (e.g., nasal polyp, septonasal arcuation, hypertrophic rhinitis), upper respiratory infection, sinusitis, infectious rhinitis, ocular infection and those disease severe enough to interfere with assessment of effectiveness
- Patients who have rhinitis medicamentosa, or nonallergic rhinitis (e.g., vasomotor rhinitis, eosinophilia rhinitis)
- Patient has a disease of the cardiovascular, hepatic, renal, hematologic systems, or other severe disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The change from baseline in the composite nasal symptoms score (average over the 2-week treatment period) in seasonal allergic rhinitis
- Secondary Outcome Measures
Name Time Method